Axonis Therapeutics Overview
- Year Founded
-
2019
- Status
-
Private
- Employees
-
21
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
32
Axonis Therapeutics General Information
Description
Operator of a neuro-focused biotechnology company intended to develop medicines targeting a critical mediator of inhibitory neurotransmission in the brain. The company has developed a proprietary neuron-specific K-Cl cotransporter (KCC2) discovery platform, enabling the healthcare industry to develop treatments for neurological disorders such as epilepsy, pain, and other central nervous system conditions.
Contact Information
Website
www.axonis.usCorporate Office
- 75 Kneeland Street
- 14th Floor
- Boston, MA 02111
- United States
Corporate Office
- 75 Kneeland Street
- 14th Floor
- Boston, MA 02111
- United States
Axonis Therapeutics Timeline
Axonis Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 18. Accelerator/Incubator | Completed | Clinical Trials - Phase 1 | ||||
| 17. Later Stage VC (Series A) | 30-Oct-2024 | Completed | Clinical Trials - Phase 1 | |||
| 16. Accelerator/Incubator | 01-Oct-2024 | Completed | Pre-Clinical Trials | |||
| 15. Seed Round | 22-Mar-2024 | Completed | Pre-Clinical Trials | |||
| 14. Grant | 01-Jan-2023 | Completed | Pre-Clinical Trials | |||
| 13. Grant | 24-Sep-2022 | Completed | Pre-Clinical Trials | |||
| 12. Grant | 01-Sep-2022 | Completed | Pre-Clinical Trials | |||
| 11. Seed Round | 10-Aug-2022 | Completed | Pre-Clinical Trials | |||
| 10. Accelerator/Incubator | 15-Jul-2022 | $9.6M | Completed | Pre-Clinical Trials | ||
| 9. Seed Round | 28-Jun-2021 | $5M | $9.6M | Completed | Pre-Clinical Trials |
Axonis Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A | ||||||||
| Seed-3 | ||||||||
| Seed-2 | ||||||||
| Seed-1 | ||||||||
| Seed Acceleration | 9,345,782 | $0.000100 | 6% | $1.18 | $1.18 | 1x | $1.18 | 7.65% |
| Seed | 1,067,536 | $0.000100 | 6% | $3.56 | $3.56 | 1x | $3.56 | 0.87% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Axonis Therapeutics Patents
Axonis Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026207340-A1 | Kcc2 potentiators and uses thereof | Pending | 28-Mar-2025 | ||
| WO-2026193233-A1 | Kcc2 potentiators and uses thereof | Pending | 12-Mar-2025 | ||
| WO-2026174141-A1 | Kcc2 potentiators and uses thereof | Pending | 14-Feb-2025 | ||
| WO-2026174141-A8 | Kcc2 potentiators and uses thereof | Pending | 14-Feb-2025 | ||
| WO-2026136888-A1 | Fused azines as kcc2 potentiators and uses thereof | Pending | 20-Dec-2024 | C07D487/04 |
Axonis Therapeutics Signals
Axonis Therapeutics Investors (32)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Cormorant Asset Management | PE/Buyout | Minority | ||
| Hatteras Venture Partners | Venture Capital | Minority | ||
| Lumira Ventures | Venture Capital | Minority | ||
| MRL Ventures Fund | Corporate Venture Capital | Minority | ||
| Perceptive Advisors | Venture Capital | Minority |
Axonis Therapeutics FAQs
-
When was Axonis Therapeutics founded?
Axonis Therapeutics was founded in 2019.
-
Where is Axonis Therapeutics headquartered?
Axonis Therapeutics is headquartered in Boston, MA.
-
What is the size of Axonis Therapeutics?
Axonis Therapeutics has 21 total employees.
-
What industry is Axonis Therapeutics in?
Axonis Therapeutics’s primary industry is Drug Discovery.
-
Is Axonis Therapeutics a private or public company?
Axonis Therapeutics is a Private company.
-
What is Axonis Therapeutics’s current revenue?
The current revenue for Axonis Therapeutics is .
-
How much funding has Axonis Therapeutics raised over time?
Axonis Therapeutics has raised $150M.
-
Who are Axonis Therapeutics’s investors?
Cormorant Asset Management, Hatteras Venture Partners, Lumira Ventures, MRL Ventures Fund, and Perceptive Advisors are 5 of 32 investors who have invested in Axonis Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process